Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Emerg Infect Dis ; 25(3): 406-415, 2019 03.
Article in English | MEDLINE | ID: mdl-30789135

ABSTRACT

In this retrospective study, we used whole-genome sequencing (WGS) to delineate transmission dynamics, characterize drug-resistance markers, and identify risk factors of transmission among Papua New Guinea residents of the Torres Strait Protected Zone (TSPZ) who had tuberculosis diagnoses during 2010-2015. Of 117 isolates collected, we could acquire WGS data for 100; 79 were Beijing sublineage 2.2.1.1, which was associated with active transmission (odds ratio 6.190, 95% CI 2.221-18.077). Strains were distributed widely throughout the TSPZ. Clustering occurred more often within than between villages (p = 0.0013). Including 4 multidrug-resistant tuberculosis isolates from Australia citizens epidemiologically linked to the TSPZ into the transmission network analysis revealed 2 probable cross-border transmission events. All multidrug-resistant isolates (33/104) belonged to Beijing sublineage 2.2.1.1 and had high-level isoniazid and ethionamide co-resistance; 2 isolates were extensively drug resistant. Including WGS in regional surveillance could improve tuberculosis transmission tracking and control strategies within the TSPZ.


Subject(s)
Emigration and Immigration , Mycobacterium tuberculosis/drug effects , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/microbiology , Antitubercular Agents/pharmacology , Australia/epidemiology , Bacterial Typing Techniques , Evolution, Molecular , Genotype , Geography , History, 21st Century , Humans , Microbial Sensitivity Tests , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/isolation & purification , Papua New Guinea/epidemiology , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/history , Whole Genome Sequencing
2.
Article in English | MEDLINE | ID: mdl-27720653

Subject(s)
Oral Medicine , Humans
3.
J Alzheimers Dis ; 45(3): 797-811, 2015.
Article in English | MEDLINE | ID: mdl-25624418

ABSTRACT

Studies have shown an increased expression of mitochondrial ferritin (FtMt) and an antioxidant role for the protein in the brains of Alzheimer's disease (AD) patients. However, little information is available concerning the role of FtMt in other AD pathologies, including inflammation and amyloidogenesis. Therefore, we investigated the regulation and function of FtMt in inflammation and amyloidogenesis. FtMt protein expression was increased by proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß), and interleukin 6 (IL-6), whereas FtMt mRNA levels were increased by TNF-α but not by IL-1ß or IL-6 in IMR-32 cells. The transcription factor nuclear factor-κB (NF-κB) inhibitor, Bay 11-7082, suppressed this TNF-α-induced FtMt expression. FtMt overexpression increased NF-κB activity and translocation of p65 into the nucleus in HEK293 cells. Conversely, knockdown of FtMt attenuated TNF-α-induced NF-κB activity. Overexpression of FtMt inhibited TNF-α-induced apoptosis in the cell culture. FtMt overexpression reduced iron-mediated expression of amyloid-ß protein precursor and decreased NF-κB-dependent increases in ß- and γ-secretase, leading to decreased amyloid-ß production. Our data provide new insights into the mechanism underlying the regulation of FtMt expression by proinflammatory cytokines and indicate further roles for FtMt in AD.


Subject(s)
Cytokines/pharmacology , Ferritins/metabolism , Mitochondrial Proteins/metabolism , Up-Regulation/drug effects , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Peptides/metabolism , Apoptosis/drug effects , Apoptosis/genetics , Aspartic Acid Endopeptidases/metabolism , Cell Line , Cycloheximide/pharmacology , Dose-Response Relationship, Drug , Ferritins/genetics , Humans , Mitochondrial Proteins/genetics , NF-kappa B/antagonists & inhibitors , Nitriles/pharmacology , Oxidoreductases , Protein Synthesis Inhibitors/pharmacology , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Sulfones/pharmacology , Time Factors , Transcription Factor RelA/metabolism , Transfection
4.
Acta Histochem Cytochem ; 47(2): 75-83, 2014 May 01.
Article in English | MEDLINE | ID: mdl-25221366

ABSTRACT

The TRK-fused gene (TFG) was originally identified in chromosome translocation events, creating a pair of oncogenes in some cancers, and was recently demonstrated as the causal gene of hereditary motor and sensory neuropathy with proximal dominant involvement. Recently, we cloned an alternative splicing variant of Tfg from a cDNA library of the rat retina, tentatively naming it retinal Tfg (rTfg). Although the common form of Tfg is ubiquitously expressed in most rat tissues, rTfg expression is localized to the central nervous system. In this study, we produced an antibody against an rTFG-specific amino acid sequence and used it to examine the localization of rTFG-like protein in the rat retina by immunohistochemistry and Western blots. Western blot analysis showed that the antibody detected a single band of 24 kDa in the rat retina. When we examined rTFG recombinant protein, the antibody detected two bands of about 42 kDa and 24 kDa. The results suggest that the 24 kDa rTFG-like protein is a fragment of rTFG. In our immunohistochemical studies of the rat retina, rTFG-like immunoreactivity was observed in all calbindin D-28K-positive horizontal cells and in some syntaxin 1-positive amacrine cells (ACs). In addition, the rTFG-like immunopositive ACs were actually glycine transporter 1-positive glycinergic or glutamate decarboxylase-positive GABAergic ACs. Our findings indicate that this novel 24 kDa rTFG-like protein may play a specific role in retinal inhibitory interneurons.

5.
Expert Rev Anti Infect Ther ; 11(10): 1097-113, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24124799

ABSTRACT

Acute and chronic inflammation commonly occurs throughout the oral cavity. The most common causes are physical damage and microbial infections, and less frequently immune reactions and malignant changes. All of these processes result in the induction of antimicrobial peptides, chemokines and cytokines that lead to cellular infiltrates, a vascular response, tissue destruction and cellular proliferation. A fascinating concept developing in the current literature suggests that antimicrobial peptides modulate the production of chemokines, cytokines and other cellular mediators and that this may have a larger ramification as an underlying mechanism mediating inflammation. Here, we propose that the ability of antimicrobial peptides to induce chemokines and anti-inflammatory or proinflammatory cytokines plays an important role in the early events of oral inflammation and may be a target for the prevention or treatment of oral inflammatory conditions.


Subject(s)
Antimicrobial Cationic Peptides/biosynthesis , Bacterial Infections/immunology , Cytokines/biosynthesis , Immunomodulation , Mouth/immunology , Anti-Inflammatory Agents/therapeutic use , Antimicrobial Cationic Peptides/immunology , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Cytokines/immunology , Humans , Immunity, Innate , Inflammation/drug therapy , Inflammation/immunology , Inflammation/microbiology , Lactoferrin/immunology , Lactoferrin/metabolism , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/immunology , Mouth/drug effects , Mouth/microbiology , Protein Binding , Saliva/chemistry , Saliva/immunology
6.
Article in English | MEDLINE | ID: mdl-23672830

ABSTRACT

OBJECTIVE: In 2005, the World Health Organization reclassified the parakeratinizing odontogenic keratocyst as a neoplasm. This article reviews the research leading to this reclassification, and validates a new survey tool that can be easily used to pool surgical and recurrence data from multiple offices. STUDY DESIGN: All odontogenic lesions accessioned in the Iowa Surgical Oral Pathology Laboratory between 1949 and 2010 were identified from the database. A survey tool to assess treatment and follow-up was created. A total of 46 surgeons agreed to participate. RESULTS: A total of 70 keratocystic odontogenic tumors (KOTs) had documented recurrences at follow-up intervals ranging from 6 months to 5 years. Primary tumors that recurred ranged in size as measured by greatest radiographic diameter from 0.7 to 6 cm. CONCLUSIONS: This survey tool is recommended as standard allowing treatment of cases by multiple practitioners to be compared retrospectively or prospectively.


Subject(s)
Data Collection/methods , Genes, Tumor Suppressor/physiology , Jaw Neoplasms , Odontogenic Cysts , Female , Humans , Jaw Neoplasms/genetics , Jaw Neoplasms/pathology , Jaw Neoplasms/therapy , Male , Neoplasm Recurrence, Local , Odontogenic Cysts/genetics , Odontogenic Cysts/pathology , Odontogenic Cysts/therapy , Retrospective Studies
7.
Int J Dent ; 2012: 871532, 2012.
Article in English | MEDLINE | ID: mdl-23304148

ABSTRACT

Background. Cone beam computed tomography (CBCT) has gained widespread acceptance in dentistry for a variety of applications. Most dentists who are not radiologists/trained in radiology are generally not familiar with interpretation of anatomical structures and/or pathosis outside their area of primary interest, as often this was not within the scope of their training. Objectives. To assess that the number of incidental findings on a CBCT scan is high both within and outside of the primary area of interest, thereby emphasizing the importance of interpretation of all areas visualized on the scan. Materials and Methods. An oral and maxillofacial radiologist reviewed 1000 CBCT scans (382 males and 618 females) for findings both in- and outside the area of interest. Results. Of the 1000 subjects that were reviewed, 943 scans showed findings in the primary regions of interest and/or outside the regions of interest, and 76 different conditions were visualized in these scans both in and outside the areas of interest. Conclusion. From the wide scope of findings noted on these scans, it can be concluded that it is essential that a person trained in advanced interpretation techniques in radiology interprets cone beam computed tomography scans.

8.
Synapse ; 64(6): 460-6, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20175220

ABSTRACT

Nitric oxide (NO) acts in the nervous system to activate guanylyl cyclase and increase cGMP. One target for cGMP appears to be the cGMP-stimulated phosphodiesterase (PDE2A), which is widely expressed in the brain and provides a molecular mechanism for NO to regulate cAMP levels. We have found that PDE2A is highly expressed in the medium spiny neurons of the striatum, which project to the pallidum and substantia nigra. These cells express dopamine-stimulated adenylyl cyclase, and we have found that increases in cAMP in these neurons, produced by activation of the D1-type dopamine receptor, are dramatically enhanced by the general phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine and the PDE2A-selective inhibitor erythro-p-(2-hydroxyl-3-nonyl)adenine (EHNA). These results indicate that PDE2A plays a major role in regulating dopamine-stimulated cAMP production in striatal neurons. EHNA also enhances NO-induced increases in striatal cGMP. In addition, dopamine appears to act via another receptor, activated by the agonist SKF83959, to increase striatal cGMP in a NO-dependent manner. Together, these observations indicate that striatal NO producing interneurons can act via the PDE2A in the medium spiny neurons to regulate the cAMP response to dopamine stimulation.


Subject(s)
Corpus Striatum/metabolism , Cyclic GMP/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 2/metabolism , Neurons/metabolism , Nitric Oxide/metabolism , Adenylyl Cyclases/metabolism , Animals , Cells, Cultured , Dopamine/metabolism , Dopamine/pharmacology , Dopamine Agonists/pharmacology , Enzyme Inhibitors/pharmacology , Interneurons/metabolism , Neural Pathways/metabolism , Rats , Rats, Wistar , Receptors, Dopamine/drug effects , Receptors, Dopamine/metabolism , Signal Transduction/physiology
9.
Prog Neurobiol ; 90(2): 246-55, 2010 Feb 09.
Article in English | MEDLINE | ID: mdl-19853011

ABSTRACT

Nitric oxide was identified as a biological intercellular messenger just over 20 years ago, and its presence and potential importance in the nervous system was immediately noted. With the cloning of NO synthase and the physiological NO receptor soluble guanylyl cyclase, a variety of histochemical methods quickly led to a rather complete picture of where NO is produced and acts in the nervous system. However, the details regarding the subcellular localization of NO synthase and the identity of its molecular binding partners require further clarification. Although the hypothesis that calcium influx via activation of NMDA receptors is a key trigger for NO production has proven very popular and led to suggested roles for NO in synaptic plasticity, there is little direct evidence to support this notion. Instead, studies from the peripheral nervous system indicate a key role for voltage-sensitive calcium channels in regulating NO synthase activity. A similar mechanism may also be important in central neurons, and it remains an important task to identify the precise sources of calcium regulating NO production in specific NO neurons. Also, although cGMP production appears to mediate the physiological signaling by NO, the specific roles of cGMP-dependent ion channels, protein kinases and phosphodiesterases in mediating NO action remain to be determined.


Subject(s)
Nervous System/cytology , Neurons/metabolism , Neurotransmitter Agents/metabolism , Nitric Oxide/metabolism , Signal Transduction/physiology , Animals , Humans , Nervous System/metabolism
10.
Biochem Biophys Res Commun ; 336(2): 565-71, 2005 Oct 21.
Article in English | MEDLINE | ID: mdl-16140270

ABSTRACT

Microsomal cytochrome P450 reductase catalyzes the one-electron transfer from NADPH via FAD and FMN to various electron acceptors, such as cytochrome P450s or to some anti-cancer quinone drugs. This results in generation of free radicals and toxic oxygen metabolites, which can contribute to the cytotoxicity of these compounds. Recently, a cytosolic NADPH-dependent flavin reductase, NR1, has been described which is highly homologous to the microsomal cytochrome P450 reductase. In this study, we show that over-expression of NR1 in human embryonic kidney cells enhances the cytotoxic action of the model quinone, menadione. Furthermore, we show that a novel human histidine triad protein DCS-1, which is expressed together with NR1 in many tissues, can significantly reduce menadione-induced cytotoxicity in these cells. We also show that DCS-1 binds NF1 and directly modulates its activity. These results suggest that NR1 may play a role in carcinogenicity and cell death associated with one-electron reductions.


Subject(s)
Cell Survival/physiology , Flavoproteins/metabolism , Kidney/cytology , Kidney/metabolism , N-Glycosyl Hydrolases/metabolism , Oxidoreductases/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Vitamin K 3/administration & dosage , Cell Line , Cell Survival/drug effects , Dose-Response Relationship, Drug , Flavoproteins/genetics , Humans , Kidney/drug effects , N-Glycosyl Hydrolases/genetics , Oxidoreductases/genetics , Saccharomyces cerevisiae Proteins/genetics , Signal Transduction/drug effects , Signal Transduction/physiology
11.
Article in English | MEDLINE | ID: mdl-16122667

ABSTRACT

Primary intraosseous carcinoma of the mandible is rare, and when it occurs often arises within or closely associated with an odontogenic cyst. The purpose of this article is to show the role of computed tomography (CT) in the early detection of carcinomatous changes, because of its specificity in establishing the nature of the lesion. An unusual case of a squamous cell carcinoma that arose in an odontogenic cyst is described. The appearance on the panoramic radiograph was suggestive of a benign cystic lesion in the left side of the mandible, but when a CT scan was performed, the appearance of the lesion was compatible with malignancy. Histopathological analysis confirmed the suspicion of a squamous cell carcinoma, but without CT investigation it would be impossible to demonstrate that carcinomatous change had developed from a cystic lesion.


Subject(s)
Carcinoma, Squamous Cell/diagnostic imaging , Mandibular Diseases/pathology , Mandibular Neoplasms/diagnostic imaging , Odontogenic Cysts/pathology , Aged , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/pathology , Female , Humans , Mandibular Neoplasms/pathology , Radiography, Panoramic , Tomography, X-Ray Computed
12.
Eur J Pharmacol ; 514(2-3): 91-8, 2005 May 09.
Article in English | MEDLINE | ID: mdl-15910796

ABSTRACT

The entry of lymphocytes into the brain is normally limited by the blood-brain barrier, however, during inflammation prominent lymphocytic infiltration occurs. In this study, we investigated the effects of nitric oxide (NO) on the adhesion of T cells to cultured human brain microvessel endothelial cells. T cell adhesion to unstimulated or tumor necrosis factor-alpha (TNF-alpha)-treated cells was quantified by counting the number of lymphocytes bound to the monolayer by light microscopy. TNF-alpha increased T cell adhesion in a time-dependent manner. Incubation of monolayers with NO donors decreased adhesion. This effect was blocked by a guanylyl cyclase inhibitor and mimicked by a cGMP agonist, and was thus dependent on the generation of cGMP. NO did not modulate adhesion molecule expression in the endothelial cells, suggesting an action on the T cells. Pre-treatment of T cells with NO or a cGMP agonist decreased binding to recombinant endothelial adhesion molecules. These findings suggest that NO can modulate the adhesion of T cells to human brain microvessel endothelial cells via a cGMP-dependent mechanism, and may thus regulate lymphocyte traffic during central nervous system inflammation.


Subject(s)
Cyclic GMP/analogs & derivatives , Cyclic GMP/metabolism , Endothelial Cells/cytology , Nitric Oxide/physiology , Signal Transduction/physiology , T-Lymphocytes/cytology , Brain/blood supply , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cells, Cultured , Cyclic GMP/pharmacology , Dose-Response Relationship, Drug , E-Selectin/pharmacology , Enzyme Inhibitors/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Humans , Intercellular Adhesion Molecule-1/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitroprusside/pharmacology , Nitroso Compounds/pharmacology , Oxadiazoles/pharmacology , Platelet Endothelial Cell Adhesion Molecule-1/pharmacology , Quinoxalines/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Vascular Cell Adhesion Molecule-1/pharmacology
13.
Exp Neurol ; 190(2): 446-55, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15530883

ABSTRACT

The endothelial cells (EC) of the microvasculature in the brain form the anatomical basis of the blood-brain barrier (BBB). In the present study, the effects of agents that modify the permeability of a well-established in vitro model of the human BBB were studied. The monolayers formed by confluent human brain microvessel endothelial cell (HBMEC) cultures are impermeable to the macromolecule tracer horseradish peroxidase (HRP) and have high electrical resistance. Exposure of HBMEC to various cytokines including TNF-alpha, IL-1beta, interferon gamma (IFN-gamma), or lipopolysaccharide (LPS) decreased transendothelial electrical resistance (TEER) mainly by increasing the permeability of the tight junctions. Primary cultures of HBMEC express endothelial nitric oxide synthase (eNOS) and produce low levels of NO. Treatment with the NO donors sodium nitroprusside (SNP) and DETA NONOate or the cGMP agonist 8-Br-cGMP significantly increased monolayer resistance. Conversely, inhibition of soluble guanylyl cyclase with ODQ rapidly decreased the resistance, and pretreatment of HBMEC with Rp-8-CPT-cGMPS, an inhibitor of cGMP-dependent protein kinase, partially prevented the 8-Br-cGMP-induced increase in resistance. Furthermore, NO donors and 8-Br-cGMP could also reverse the increased permeability of the monolayers induced by IL-1beta, IFN-gamma, and LPS. These results indicate that NO can decrease the permeability of the human BBB through a mechanism at least partly dependent on cGMP production and cGMP-dependent protein kinase activation.


Subject(s)
Blood-Brain Barrier/physiology , Cyclic GMP/analogs & derivatives , Cyclic GMP/metabolism , Cytokines/metabolism , Endothelial Cells/physiology , Nitric Oxide/metabolism , Capillary Permeability/drug effects , Capillary Permeability/physiology , Cells, Cultured , Cyclic GMP/pharmacology , Electric Impedance , Endothelial Cells/drug effects , Enzyme Inhibitors/pharmacology , Humans , Immunohistochemistry , In Vitro Techniques , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Nitroso Compounds/pharmacology , Oxadiazoles/pharmacology , Quinoxalines/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology
14.
Biochem Biophys Res Commun ; 323(1): 142-8, 2004 Oct 08.
Article in English | MEDLINE | ID: mdl-15351713

ABSTRACT

The hypothesis that the NO/cGMP pathway modulates PMN adhesion to human brain microvessel endothelial cells (HBMEC) was examined. Human PMN were incubated with resting or TNF-alpha-treated endothelial monolayers, and adhesion was quantified by light microscopy. TNF-alpha upregulated PMN adhesion in a time-dependent manner. Treatment of HBMEC with the NO donors SNP and DETA NONOate for 4 or 24 h decreased PMN adhesion. This was completely reversed by the guanylyl cyclase inhibitor ODQ, while addition of a cGMP agonist (8-Br-cGMP) decreased PMN adhesion. NO donors did not affect the levels of E-selectin or ICAM-1 in HBMEC. However, pre-treatment of PMN with NO donors or 8-Br-cGMP decreased their adhesion to recombinant E-selectin and ICAM-1, suggesting an effect of NO on PMN. These findings indicate that NO modulates PMN-HBMEC interactions through cGMP and decreases the binding of PMN to the adhesion molecules E-selectin and ICAM-1.


Subject(s)
Brain/blood supply , Endothelial Cells/cytology , Endothelium, Vascular/cytology , Neutrophils/metabolism , Nitric Oxide/metabolism , Blotting, Western , Cell Adhesion , Cells, Cultured , Cyclic GMP-Dependent Protein Kinases/metabolism , E-Selectin/metabolism , Humans , Inflammation , Intercellular Adhesion Molecule-1/metabolism , Microcirculation , Models, Biological , Nitroso Compounds/pharmacology , Signal Transduction , Time Factors , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation
16.
J Biol Chem ; 278(40): 39051-8, 2003 Oct 03.
Article in English | MEDLINE | ID: mdl-12871939

ABSTRACT

A novel human cytosolic flavin reductase, Nr1, was recently described that contains FMN, FAD, and NADPH cofactors. Though the targets of the related NADPH-dependent flavoprotein reductases, cytochrome P450 reductase, methionine synthase reductase, and nitric oxide synthase, are known, the cellular function of Nr1 is not clear. To explore expression and regulation of Nr1, we cloned fre-1, the Caenorhabditis elegans ortholog of Nr1, and discovered that it is transcribed as a bicistronic pre-mRNA together with dcs-1, the ortholog of the recently described scavenger mRNA decapping enzyme. We used the novel substrate, 7meGpppBODIPY, to demonstrate that DCS-1 has low micromolar specificity for guanine ribonucleotides with the 7me modification, whereas trimethylated G substrates are poor competitors. Contrary to earlier classification, DCS-1 is not a pyrophosphatase but a distant member of the Hint branch of the histidine triad superfamily of nucleotide hydrolases and transferases. These observations are consistent with the hypothesis that DCS-1 homologs may function in the metabolism of capped oligonucleotides generated following exosome-dependent degradation of short-lived mRNA transcripts. We find that fre-1 and dcs-1 are coordinately expressed through worm development, are induced by heat shock, and have a nearly identical expression profile in human tissues. Furthermore, immunocytochemical analysis of the endogenous proteins in COS cells indicates that both are present in the nucleus and concentrated in a distinct perinuclear structure. Though no connection between these enzymes had been anticipated, our data and data from global expression and protein association studies suggest that the two enzymes jointly participate in responses to DNA damage, heat shock, and other stresses.


Subject(s)
Caenorhabditis elegans/chemistry , FMN Reductase/chemistry , FMN Reductase/genetics , Hydrolases/genetics , N-Glycosyl Hydrolases/biosynthesis , N-Glycosyl Hydrolases/chemistry , Saccharomyces cerevisiae Proteins/biosynthesis , Saccharomyces cerevisiae Proteins/chemistry , Amino Acid Sequence , Animals , Animals, Genetically Modified , Boron Compounds/pharmacology , COS Cells , Caenorhabditis elegans Proteins , Cell Nucleus/metabolism , Cloning, Molecular , DNA Damage , Histidine/chemistry , Hot Temperature , Humans , Hydrolases/chemistry , Immunohistochemistry , Kinetics , Molecular Sequence Data , NADP/metabolism , Operon , Pyrophosphatases/metabolism , RNA, Messenger/metabolism , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Time Factors , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...